Candel Therapeutics, Inc.CADLNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+47.6%
5Y CAGR+103.9%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+47.6%/yr
Annual compound
5Y CAGR
+103.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
35.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$3.92M+260.5%
2024$1.09M-
2023$0.00-100.0%
2022$1.22M-
2021$0.00-100.0%
2020$111000.00-89.6%
2019$1.07M-